140 related articles for article (PubMed ID: 35306936)
1. The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII.
Bonardi A; Bua S; Combs J; Lomelino C; Andring J; Osman SM; Toti A; Di Cesare Mannelli L; Gratteri P; Ghelardini C; McKenna R; Nocentini A; Supuran CT
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):930-939. PubMed ID: 35306936
[TBL] [Abstract][Full Text] [Related]
2. Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and
Abdelrahman MA; Eldehna WM; Nocentini A; Ibrahim HS; Almahli H; Abdel-Aziz HA; Abou-Seri SM; Supuran CT
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):298-305. PubMed ID: 31809607
[TBL] [Abstract][Full Text] [Related]
3. Tailored Tetrasubstituted Imidazole Carrying the Benzenesulfonamide Fragments as Selective Human Carbonic Anhydrase IX/XII Inhibitors.
Taher ES; Marzouk AA; Abd-Allah WH; Giovannuzzi S; Ibrahim TS; Supuran CT; El Hamd MA; El-Behairy MF
ChemMedChem; 2024 May; 19(10):e202400004. PubMed ID: 38356418
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 2,4-thiazolidinedione-tethered coumarins as novel selective inhibitors for carbonic anhydrase IX and XII isoforms.
Eldehna WM; Taghour MS; Al-Warhi T; Nocentini A; Elbadawi MM; Mahdy HA; Abdelrahman MA; Alotaibi OJ; Aljaeed N; Elimam DM; Afarinkia K; Abdel-Aziz HA; Supuran CT
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):531-541. PubMed ID: 34991416
[TBL] [Abstract][Full Text] [Related]
5. Development of Novel Quinoline-Based Sulfonamides as Selective Cancer-Associated Carbonic Anhydrase Isoform IX Inhibitors.
Shaldam M; Nocentini A; Elsayed ZM; Ibrahim TM; Salem R; El-Domany RA; Capasso C; Supuran CT; Eldehna WM
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681794
[TBL] [Abstract][Full Text] [Related]
6. A potentiated cooperation of carbonic anhydrase IX and histone deacetylase inhibitors against cancer.
Ruzzolini J; Laurenzana A; Andreucci E; Peppicelli S; Bianchini F; Carta F; Supuran CT; Romanelli MN; Nediani C; Calorini L
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):391-397. PubMed ID: 31865754
[TBL] [Abstract][Full Text] [Related]
7. Effective Anticancer Potential of a New Sulfonamide as a Carbonic Anhydrase IX Inhibitor Against Aggressive Tumors.
Koyuncu I; Temiz E; Güler EM; Durgun M; Yuksekdag O; Giovannuzzi S; Supuran CT
ChemMedChem; 2024 May; 19(9):e202300680. PubMed ID: 38323458
[TBL] [Abstract][Full Text] [Related]
8. Ureidobenzenesulfonamides as Selective Carbonic Anhydrase I, IX, and XII Inhibitors.
Denner TC; Angeli A; Ferraroni M; Supuran CT; Csuk R
Molecules; 2023 Nov; 28(23):. PubMed ID: 38067512
[TBL] [Abstract][Full Text] [Related]
9. First studies on tumor associated carbonic anhydrases IX and XII monoclonal antibodies conjugated to small molecule inhibitors.
Testa C; Papini AM; Zeidler R; Vullo D; Carta F; Supuran CT; Rovero P
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):592-596. PubMed ID: 35057692
[TBL] [Abstract][Full Text] [Related]
10. Screening Campaign and Docking Investigations in Identifying New Hit Compounds as Inhibitors of Human Carbonic Anhydrases Expressed In Tumour Cells.
Ricci F; Angeli A; Mancuso F; De Luca L; Supuran CT; Gitto R
ChemMedChem; 2023 Oct; 18(20):e202300330. PubMed ID: 37694943
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory activity against carbonic anhydrase IX and XII as a candidate selection criterion in the development of new anticancer agents.
Krasavin M; Kalinin S; Sharonova T; Supuran CT
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1555-1561. PubMed ID: 32746643
[TBL] [Abstract][Full Text] [Related]
12. A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: Design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessments.
Hefny SM; El-Moselhy TF; El-Din N; Ammara A; Angeli A; Ferraroni M; El-Dessouki AM; Shaldam MA; Yahya G; Al-Karmalawy AA; Supuran CT; Tawfik HO
Eur J Med Chem; 2024 Aug; 274():116527. PubMed ID: 38810335
[TBL] [Abstract][Full Text] [Related]
13. Structural Basis of Saccharin Derivative Inhibition of Carbonic Anhydrase IX.
Leitans J; Kazaks A; Bogans J; Supuran CT; Akopjana I; Ivanova J; Zalubovskis R; Tars K
ChemMedChem; 2023 Nov; 18(22):e202300454. PubMed ID: 37837260
[TBL] [Abstract][Full Text] [Related]
14. New sulfonamide-based glycosides incorporated 1,2,3-triazole as cytotoxic agents through VEGFR-2 and carbonic anhydrase inhibitory activity.
Abbas HS; Nossier ES; El-Manawaty MA; El-Bayaa MN
Sci Rep; 2024 Jun; 14(1):13028. PubMed ID: 38844493
[TBL] [Abstract][Full Text] [Related]
15. 2H-chromene and 7H-furo-chromene derivatives selectively inhibit tumour associated human carbonic anhydrase IX and XII isoforms.
Sequeira L; Distinto S; Meleddu R; Gaspari M; Angeli A; Cottiglia F; Secci D; Onali A; Sanna E; Borges F; Uriarte E; Alcaro S; Supuran CT; Maccioni E
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2270183. PubMed ID: 37870190
[TBL] [Abstract][Full Text] [Related]
16. Handling drug-target selectivity: A study on ureido containing Carbonic Anhydrase inhibitors.
Akgul O; Singh S; Andring JT; McKenna R; Selleri S; Carta F; Angeli A; Supuran CT
Eur J Med Chem; 2021 Feb; 212():113035. PubMed ID: 33303238
[TBL] [Abstract][Full Text] [Related]
17. Small Molecule Alkoxy Oriented Selectiveness on Human Carbonic Anhydrase II and IX Inhibition.
Bozdag M; Cravey L; Combs J; Kota A; McKenna R; Angeli A; Selleri S; Carta F; Supuran CT
ChemMedChem; 2022 Jun; 17(11):e202200148. PubMed ID: 35388618
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of diaryl urea molecules with and without sulfonamide group on Carbonic anhydrase IX and XII inhibition and its consequence on breast cancer cells.
Debnath J; Keshamasetthy D; Combs J; Leon K; Vullo D; Chatterjee A; McKenna R; Supuran CT
Bioorg Chem; 2024 Apr; 145():107192. PubMed ID: 38382393
[TBL] [Abstract][Full Text] [Related]
19. Discovery and Mechanistic Studies of Dual-Target Hits for Carbonic Anhydrase IX and VEGFR-2 as Potential Agents for Solid Tumors: X-ray,
Hefny SM; El-Moselhy TF; El-Din N; Giovannuzzi S; Bin Traiki T; Vaali-Mohammed MA; El-Dessouki AM; Yamaguchi K; Sugiura M; Shaldam MA; Supuran CT; Abdulla MH; Eldehna WM; Tawfik HO
J Med Chem; 2024 May; 67(9):7406-7430. PubMed ID: 38642371
[TBL] [Abstract][Full Text] [Related]
20. The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy.
Andreucci E; Ruzzolini J; Peppicelli S; Bianchini F; Laurenzana A; Carta F; Supuran CT; Calorini L
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):117-123. PubMed ID: 30362384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
